Gotowa bibliografia na temat „Age-related macular degeneration”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Age-related macular degeneration”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Age-related macular degeneration"

1

SR, Bharathidevi. "Elevated Serum Hydrogen Sulfide in Age Related Macular Degeneration". Open Access Journal of Ophthalmology 8, nr 2 (5.07.2023): 1–6. http://dx.doi.org/10.23880/oajo-16000281.

Pełny tekst źródła
Streszczenie:
Introduction: Age related macular degeneration is one of the major causes of global blindness and vision impairment. The study was done to determine the levels of hydrogen sulfide (H2S) in AMD subjects in the study cohort. Methods: Twenty-six blood samples were collected, 12 control and 14 AMD subjects, the serum obtained from these samples were used for the measurement of H2S by Methylene blue (MB) assay and IL6 using ELISA. Results: We observed that both the levels of H2S and IL6 to be elevated in AMD subjects when compared to control and H2S and IL6 showed a positive correlation. Conclusion: We propose H2S to be a marker in both dry and wet AMD
Style APA, Harvard, Vancouver, ISO itp.
2

Bozkurt, M. K., B. T. Ozturk, H. Kerimoglu, I. Ersan, H. Arbag i B. Bozkurt. "Association of age-related macular degeneration with age-related hearing loss". Journal of Laryngology & Otology 125, nr 3 (16.12.2010): 231–35. http://dx.doi.org/10.1017/s0022215110002604.

Pełny tekst źródła
Streszczenie:
AbstractObjective:To assess the association between age-related macular degeneration and age-related hearing loss in Turkish subjects aged 50 years or older.Study design and setting:Prospective, case–control study within a tertiary university hospital.Subjects and methods:Fifty subjects with age-related macular degeneration and 43 healthy subjects underwent ophthalmological and otolaryngological examination. Statistical analyses were conducted for the poorer eye and ear, comparing age-related hearing loss and pure tone average in the macular degeneration group versus controls.Results:Median pure tone average was significantly poorer in the macular degeneration group (35 dBHL) compared with controls (23 dBHL). In the macular degeneration group, hearing loss was significantly greater in dry type (43 dBHL) than wet type (32 dBHL) cases. There was a significant difference between the prevalence of varying degrees of hearing loss in the macular degeneration versus control groups, being respectively: mild, 50 and 35 per cent; moderate, 20 and 5 per cent; and severe, 6 and 0 per cent. There was a weak, but significant correlation between each patient's visual acuity and pure tone average results (rs = −0.37, p < 0.001).Conclusion:Age-related hearing loss is more common in patients with age-related macular degeneration. Such patients should be questioned regarding hearing difficulty, and referred to an otolaryngologist if appropriate.
Style APA, Harvard, Vancouver, ISO itp.
3

Thomas, Catherine J., Rukhsana G. Mirza i Manjot K. Gill. "Age-Related Macular Degeneration". Medical Clinics of North America 105, nr 3 (maj 2021): 473–91. http://dx.doi.org/10.1016/j.mcna.2021.01.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Starr, Christopher E., David R. Guyer i Lawrence A. Yannuzzi. "Age-related macular degeneration". Postgraduate Medicine 103, nr 5 (maj 1998): 153–64. http://dx.doi.org/10.3810/pgm.1998.05.480.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Dean, Erin. "Age-related macular degeneration". Nursing Older People 30, nr 3 (23.03.2018): 12. http://dx.doi.org/10.7748/nop.30.3.12.s11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

C, Christoph Richter, i Hamdy Shaban H. "Age-Related Macular Degeneration". Journal of Medical Sciences 2, nr 1 (10.02.2009): 18–24. http://dx.doi.org/10.2174/1996327000902010018.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

O??Neill, Ciaran, James Jamison, Douglas McCulloch i David Smith. "Age-Related Macular Degeneration". Drugs & Aging 18, nr 4 (2001): 233–41. http://dx.doi.org/10.2165/00002512-200118040-00001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Lacour, Morten, Jens Folke Kiilgaard i Mogens Holst Nissen. "Age-Related Macular Degeneration". Drugs & Aging 19, nr 2 (2002): 101–33. http://dx.doi.org/10.2165/00002512-200219020-00003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Apte, Rajendra S. "Age-Related Macular Degeneration". New England Journal of Medicine 385, nr 6 (5.08.2021): 539–47. http://dx.doi.org/10.1056/nejmcp2102061.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Talbot, J. F. "Age-Related Macular Degeneration". Seminars in Ophthalmology 1, nr 3 (styczeń 1986): 179–88. http://dx.doi.org/10.3109/08820538609068778.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Rozprawy doktorskie na temat "Age-related macular degeneration"

1

Gu, Jiayin. "Biomarkers for Age-Related Macular Degeneration". Case Western Reserve University School of Graduate Studies / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1225388164.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Renganathan, Kutralanathan. "Oxidative stress and age related macular degeneration". online version, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1193002743.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Binns, Alison Mary. "Electrophysiological investigation of age-related macular degeneration". Thesis, Cardiff University, 2005. http://orca.cf.ac.uk/55964/.

Pełny tekst źródła
Streszczenie:
Age-related macular degeneration (AMD) affects 12.7 million people in Europe and North America (Klein et al., 1995 Klein et al. 1999). As a combination of decreasing birth rate and increasing longevity alter the demographic of the population, the impact of this disease can only increase. This places an immense burden, not only on the individuals afflicted by the condition, but on the financial resources of society as a whole. Unfortunately, treatment for AMD is still very restricted, and even our understanding of the pathogenesis of the disease is far from complete One concern in tackling the growing problem of AMD is that methods used in the assessment of the condition are limited, usually based on fundus appearance and visual acuity. The aim of this study was to develop a battery of electrophysiological tests which would be sensitive to the most subtle changes in retinal function in AMD. Such tests may aid diagnosis, provide a more sensitive measure of disease progression, and allow an early identification of phenotypic subtypes. Protocols were included for the recording of the focal rod ERG, the focal cone ERG, the S-cone ERG and the dynamic focal cone ERG, along with psychophysical tests of colour vision and dark adaptation. These tests were then applied to 31 subjects with ARM (12 with bilateral ARM, 11 with unilateral wet AMD and 8 with unilateral dry AMD), and 28 controls. In the analysis of ERG amplitudes a ratio of focal to full-field amplitude was introduced as a novel means of reducing intersubject variability in response. This was found to increase the accuracy of all tests in distinguishing between subject groups. The greatest separation between ARM and control groups was provided by the dynamic tests of visual function i.e. rod-cone break time of the dark adaptation function, and time constant of recovery of the dynamic focal cone ERG. The time to rod-cone break also showed potential in identifying subjects at increased risk of exudative retinal changes. Subjects were assigned to groups in this study on the basis of fundus appearance. However, individuals within each subject group showed a range of retinal function which belied the homogeneity of retinal signs. This raises the question of whether 'form' or 'function' should form the basis of classification and assessment of individuals with ARM and AMD.
Style APA, Harvard, Vancouver, ISO itp.
4

Evans, Jennifer Rosemary. "Age-related macular degeneration in the UK". Thesis, London School of Hygiene and Tropical Medicine (University of London), 2003. http://researchonline.lshtm.ac.uk/682315/.

Pełny tekst źródła
Streszczenie:
The aim of this thesis was to investigate the prevalence and impact of age-related macular degeneration (AMD) causing visual impairment in people aged 75 years and above in the UK. A secondary objective was to investigate a small number of potential risk factors for AMD. This was an add-on study to the MRC Trial of the Assessment and Management of Older People in the Community. The prevalence of AMD causing visual impairment was estimated at 3.7% (95% confidence interval 3.2% to 4.2%) in people aged 75 years and above. This prevalence increased sharply with age. There was a higher risk of AMD causing visual impairment in women. There were estimated to be approximately 192,000 people aged 75 years and above in the UK living in the community with visual impairment due to AMD (95% confidence interval 144,000 to 239,000) of whom 60,000 are aged 90 years or above. The prevalence of AMD causing visual impairment did not vary by socio-economic group or region. After controlling for appropriate confounding factors, compared to people not visually impaired, people visually impaired due to AMD were more likely to have functional difficulties, report poor health and be depressed. They were more likely to be in the worst quintile for the home management and mobility dimensions of the Sickness Impact Profile (SIP). After controlling for appropriate confounding factors including binocular acuity score, compared to people visually impaired due to other causes, people visually impaired due to AMD were more likely to have functional difficulties and report poor health and less likely to be in the worst quintile for SIP body care and movement dimension or die. There was an association between smoking status and risk of being visually impaired due to AMD. This effect was particularly strong in people aged 75-79 years of age. In these people there was a dose-response relationship between pack years of smoking and risk of AMD causing visual impairment. There were no statistically significant associations between alcohol consumption, cardiovascular disease and reproductive factors (in women) and AMD causing visual impairment.
Style APA, Harvard, Vancouver, ISO itp.
5

Goverdhan, Srinivas. "Immunogenetic pathways in age related macular degeneration". Thesis, University of Southampton, 2008. https://eprints.soton.ac.uk/66006/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Renganathan, Kutralanathan. "Oxidative Damage and Age Related Macular Degeneration". Case Western Reserve University School of Graduate Studies / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=case1193002743.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Wang, Yang. "Gene Discovery for Age-related Macular Degeneration". Case Western Reserve University School of Graduate Studies / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1228364622.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

NI, JIAQIAN. "Plasma Biomarkers for Age-Related Macular Degeneration". Cleveland State University / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=csu1236700270.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wu, Juan. "Dietary Determinants of Age-Related Macular Degeneration". Thesis, Harvard University, 2016. http://nrs.harvard.edu/urn-3:HUL.InstRepos:27201715.

Pełny tekst źródła
Streszczenie:
Age-related macular degeneration (AMD) is the most common cause of irreversible blindness in older Americans. There has been a long standing interest in the role of diet in the development of AMD. As early as the first National Health and Nutrition Examination Survey in the 1970s, higher intakes of fruits and vegetables were inversely correlated with the prevalence of AMD. Carotenoids and omega3 fatty acids are the most studied dietary factors due to strong biological plausibility. However, evidence from epidemiologic studies and clinical trials on the relations has been inconsistent. Chapter I prospectively examined the intakes of lutein/zeaxanthin and other common carotenoids in relation to the risk of AMD over more than two decades of follow-up among two large US cohorts, the Nurses’ Health Study and Health Professionals Follow-Up Study. We assessed nutrient intakes by repeated food frequency questionnaires. We also computed bioavailable plasma carotenoid scores directly from food intake using validated regression models. Cox proportional hazards models were used to compute the associations. Higher intakes of bioavailable carotenoids (except lycopene) were inversely associated with advanced AMD but not intermediate AMD. Analyses based on bioavailable intakes resulted in stronger associations than conventional nutrient intakes. Chapter II prospectively evaluated the marine long-chain omega3 fatty acids. We found that long-chain omega3 fatty acids were inversely associated with visually significant intermediate AMD. There was no association with advanced AMD; however, the totality of current evidence for advanced AMD is also discordant. Chapter III further investigated the plant-derived omega3 fatty acids, α-linolenic acid (ALA). We found that higher intake of ALA was associated with intermediate AMD before 2002 but not after. This coincides with the same time period when trans ALA was found in our participants’ blood and in mayonnaise, a primary food source of ALA. Whether trans ALA mediates this positive association warrants further studies. Although randomized trials are usually believed as the “gold standard”, dietary factors are hard to be adequately studied by randomized trials due to the complexities of diet and disease relations. Thus, findings in this thesis from large long-term prospective cohort studies provide the next best form of evidence.
Style APA, Harvard, Vancouver, ISO itp.
10

Wang, Yang. "Gene discovery of age-related macular degeneration". Cleveland, Ohio : Case Western Reserve University, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1228364622.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Książki na temat "Age-related macular degeneration"

1

Chew, Emily Y., i Anand Swaroop, red. Age-related Macular Degeneration. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-66014-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Holz, Frank G., Daniel Pauleikhoff, Richard F. Spaide i Alan C. Bird, red. Age-related Macular Degeneration. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-22107-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Wykoff, Charles, Mariam Hussain, T. Ashwini Kini i Bayan Al Othman. Age-Related Macular Degeneration. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-36973-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Alberti, Winfried E., Gisbert Richard i Robert H. Sagerman, red. Age-Related Macular Degeneration. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56439-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Holz, Frank G., Daniel Pauleikhoff, Richard F. Spaide i Alan C. Bird. Age-related macular degeneration. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-662-05199-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Windom, Robert Emerson. Age related macular degeneration. Bethesda, Md: U.S. Dept. of Health and Human Services, U.S. Public Health Service, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

1962-, Lim Jennifer I., red. Age-related macular degeneration. New York: Marcel Dekker, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

W, Berger Jeffrey, Fine Stuart L. 1942- i Maguire Maureen G, red. Age-related macular degeneration. St. Louis: Mosby, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Institute, National Eye, red. Age-related macular degeneration. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Eye Institute, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

American Academy of Ophthalmology. Retina Panel. Age-related macular degeneration. San Francisco, Calif: American Academy of Ophthalmology, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Age-related macular degeneration"

1

Penfold, Philip L., James Wong, Diana van Driel, Jan M. Provis i Michele C. Madigan. "Immunology and Age-Related Macular Degeneration". W Macular Degeneration, 25–44. Berlin, Heidelberg: Springer Berlin Heidelberg, 2005. http://dx.doi.org/10.1007/3-540-26977-0_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Makhijani, Vikram S., Cindy Ung i Deeba Husain. "Dry Age-Related Macular Degeneration". W Macular Disorders, 1–12. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-3001-2_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Theisler, Charles. "Macular Degeneration/ Age Related Macular Degeneration (AMD)". W Adjuvant Medical Care, 208–10. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-213.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Dysli, Chantal, i Lydia Sauer. "Age-Related Macular Degeneration". W Fluorescence Lifetime Imaging Ophthalmoscopy, 57–64. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-22878-1_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Rabina, Gilad, i Anat Loewenstein. "Age-Related Macular Degeneration". W Encyclopedia of Ophthalmology, 1–6. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-35951-4_984-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Khandhadia, Sam, Jocelyn Cherry i Andrew John Lotery. "Age-Related Macular Degeneration". W Advances in Experimental Medicine and Biology, 15–36. New York, NY: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-0653-2_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Yoshimura, Nagahisa, i Masanori Hangai. "Age-related macular degeneration". W OCT Atlas, 149–228. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-38625-1_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rabina, Gilad, i Anat Loewenstein. "Age-Related Macular Degeneration". W Encyclopedia of Ophthalmology, 50–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-540-69000-9_984.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hellman, Justin, i Glenn Yiu. "Age-Related Macular Degeneration". W Current Practices in Ophthalmology, 35–70. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8545-1_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Roohipoor, Ramak, Fatemeh Bazvand, Hassan Khojasteh i Fedra Hajizadeh. "Age Related Macular Degeneration". W Atlas of Ocular Optical Coherence Tomography, 27–96. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66757-7_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Age-related macular degeneration"

1

Sunness, Janet S., i Robert W. Massof. "The Focal EOG in Age-Related Macular Degeneration". W Noninvasive Assessment of Visual Function. Washington, D.C.: Optica Publishing Group, 1985. http://dx.doi.org/10.1364/navf.1985.tub1.

Pełny tekst źródła
Streszczenie:
Studies of electrooculogram testing of patients with age-related drusen and macular degeneration (aka senile macular degeneration, or SMD) have shown differing results. Of the two largest studies, one1 showed most patients with severe SMD to have low Arden ratios and most patients with drusen to have normal Arden ratios, and the other2 showed one-third of patients with drusen and SMD to have abnormal EOGs, with no correlation to severity of the clinical picture. These studies were performed using a non-ganzfeld type of stimulation. A recent study by us3 of twenty-one patients with drusen and SMD, using ganzfeld EOG testing, found that all patients had normal Arden ratios.
Style APA, Harvard, Vancouver, ISO itp.
2

van Grinsven, Mark J. J. P., Yara T. E. Lechanteur, Johannes P. H. van de Ven, Bram van Ginneken, Thomas Theelen i Clara I. Sánchez. "Automatic age-related macular degeneration detection and staging". W SPIE Medical Imaging, redaktorzy Carol L. Novak i Stephen Aylward. SPIE, 2013. http://dx.doi.org/10.1117/12.2007563.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chou, Jim-Son, i Albert C. Ting. "AMO® TeledioptricTMSystem for age-related macular degeneration". W OE/LASE '94, redaktor Donn M. Silberman. SPIE, 1994. http://dx.doi.org/10.1117/12.176834.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mohaghegh, N., E. Ghafar Zadeh i S. Magierowski. "Wearable diagnostic system for age-related macular degeneration". W 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2016. http://dx.doi.org/10.1109/embc.2016.7592097.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Miura, Masahiro, i Ann E. Eisner. "Three Dimensional Imaging in Age-Related Macular Degeneration". W Vision Science and its Applications. Washington, D.C.: OSA, 2001. http://dx.doi.org/10.1364/vsia.2001.fb3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hijazi, Mohd Hanafi Ahmad, Frans Coenen i Yalin Zheng. "Age-Related Macular Degeneration Screening Using Data Mining Approaches". W 2013 1st International Conference on Artificial Intelligence, Modelling & Simulation (AIMS). IEEE, 2013. http://dx.doi.org/10.1109/aims.2013.55.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Elsner, Ann E., Mariane B. M. Kairala, Michael C. Cheney, Stephen A. Burns i Masahiro Miura. "Imaging with polarization analysis in age-related macular degeneration". W Frontiers in Optics. Washington, D.C.: OSA, 2003. http://dx.doi.org/10.1364/fio.2003.mc4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Lipshitz, Isaac. "Intraocular Implanted Mirror Telescope For Age- Related Macular Degeneration". W Bio-Optics: Design and Application. Washington, D.C.: OSA, 2011. http://dx.doi.org/10.1364/boda.2011.btud1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ting, Albert C., Donald G. Koch i Jim-Son Chou. "Diffractive-refractive lens system for age-related macular degeneration". W OE/LASE'93: Optics, Electro-Optics, & Laser Applications in Science& Engineering, redaktorzy Jean-Marie A. Parel i Qiushi Ren. SPIE, 1993. http://dx.doi.org/10.1117/12.147526.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Burlina, P., D. E. Freund, N. Joshi, Y. Wolfson i N. M. Bressler. "Detection of age-related macular degeneration via deep learning". W 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI 2016). IEEE, 2016. http://dx.doi.org/10.1109/isbi.2016.7493240.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Age-related macular degeneration"

1

Jaganathan Geethalakshmi, Kruthica, Iyshwarya Bhaskar Kalarani i Ramakrishnan Veerabathiran. Stem cell technology to cure age-related macular degeneration (AMD). Peeref, listopad 2022. http://dx.doi.org/10.54985/peeref.2211p4104893.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Liu, Yunjie, Mengmei Ni, Rui Wu, Zhirui Yang, Xuejiao Zhu i Jinyao Chen. Lutein and age-related macular degeneration: a comprehensive systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2021. http://dx.doi.org/10.37766/inplasy2021.11.0091.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Wang, Xiaoqin, Liuzhi Zeng, Ming Chen i LongQian Liu. Choroidal vascular changes in age-related macular degeneration: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2020. http://dx.doi.org/10.37766/inplasy2020.10.0041.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kyosseva, Svetlana V., Sudipta Seal i James F. McGinnis. Cerium Oxide Nanoparticles Inhibit Map Kinases Activation in the Retina of VLDLR Mouse Model of Age-related Macular Degeneration. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, listopad 2018. http://dx.doi.org/10.7546/crabs.2018.11.07.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

SHI, Suisui, Lei YANG, Guohui Yang, Baoyu QI i Guojun CHAO. Efficacy of traditional Chinese medicine combined with ranibizumab in patients with neovascular age-related macular degeneration: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0077.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Zhang, Yun, Zhaolun Cai, Xueting Liu, Tiancong Chang, Xun Li, You Tang, Bo Zhang i Meixia Zhang. Comparative efficacy and safety of anti-vascular endothelial growth factor monotherapies for neovascular age-related macular degeneration: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2020. http://dx.doi.org/10.37766/inplasy2020.7.0007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Regular monthly and “as needed” injections for wet age-related macular degeneration are similar in effect. National Institute for Health Research, styczeń 2016. http://dx.doi.org/10.3310/signal-000185.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii